AI chatbot aims to ease symptoms of Heart-Kidney-Metabolic syndrome
NCT ID NCT07577284
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether an AI chatbot, combined with nurse support, can help adults with early-stage cardiovascular-kidney-metabolic (CKM) syndrome better manage their symptoms. 72 participants will either use the chatbot plus nurse feedback or standard symptom tracking alone. The goal is to see if the program reduces symptom burden, improves self-care, and lowers emergency visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Taipei Medical University
Taipei, No. 250่, Wuxing St, Xinyi District, Taipei City, 110, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple exercise test may unmask hidden artery damage in CKM syndrome
- Can tracking heart-kidney-metabolic syndrome in india reveal its hidden patterns?
- New study aims to uncover hidden heart risks in CKM syndrome
- Can cooking classes and exercise outperform medically tailored groceries for heart and kidney health?
- Could adding a second diabetes drug early save lives?
- Massive database aims to unlock secrets of Heart-Kidney-Metabolic syndrome